M
Maryka Quik
Researcher at Oklahoma State University Center for Health Sciences
Publications - 107
Citations - 7171
Maryka Quik is an academic researcher from Oklahoma State University Center for Health Sciences. The author has contributed to research in topics: Nicotinic agonist & Nicotine. The author has an hindex of 47, co-authored 107 publications receiving 6776 citations. Previous affiliations of Maryka Quik include SRI International.
Papers
More filters
Journal ArticleDOI
Guidelines on nicotine dose selection for in vivo research
Shannon G. Matta,David J.K. Balfour,Neal L. Benowitz,R. Thomas Boyd,Jerry J. Buccafusco,Anthony R. Caggiula,Caroline R. Craig,Allan C. Collins,M. Imad Damaj,Eric C. Donny,Phillip S. Gardiner,Sharon R. Grady,Ulrike Heberlein,Sherry Leonard,Edward D. Levin,Ronald J. Lukas,Athina Markou,Michael J. Marks,Sarah E. McCallum,Neeraja Parameswaran,Kenneth A. Perkins,Marina R. Picciotto,Maryka Quik,Jed E. Rose,Adrian Rothenfluh,William R Schafer,Ian P. Stolerman,Rachel F. Tyndale,Jeanne M. Wehner,Jeffrey M. Zirger +29 more
TL;DR: A new, experimentally based compilation of species-specific dose selection for studies on the in vivo effects of nicotine, addressing issues related to genetic background, age, acute vs chronic exposure, route of administration, and behavioral responses is provided.
Journal Article
International Union of Pharmacology. XX. Current Status of the Nomenclature for Nicotinic Acetylcholine Receptors and Their Subunits
Ronald J. Lukas,Jean-Pierre Changeux,N. Le Novere,Edson X. Albuquerque,David J.K. Balfour,Darwin K. Berg,D. Bertrand,Vincent A. Chiappinelli,P. B. S. Clarke,Allan C. Collins,J. A. Dani,Sharon R. Grady,Kenneth J. Kellar,Jon Lindstrom,Michael J. Marks,Maryka Quik,Palmer Taylor,Susan Wonnacott +17 more
TL;DR: Nicotinic acetylcholine receptors in jawed vertebrates are prototypical members of the multisubunit, neurotransmitter-gated superfamily of ion channels (ionotropic neurotransmitter receptors; see Section IV for selected seminal papers, reviews, and collections).
Journal ArticleDOI
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
Matthieu F. Bastide,Wassilios G. Meissner,Barbara Picconi,Stefania Fasano,Pierre-Olivier Fernagut,Michael Feyder,Veronica Francardo,Cristina Alcacer,Yunmin Ding,Riccardo Brambilla,Gilberto Fisone,A. Jon Stoessl,Mathieu Bourdenx,Michel Engeln,Sylvia Navailles,Philippe De Deurwaerdère,Wai Kin D. Ko,Nicola Simola,Micaela Morelli,Laurent Groc,Maria Cruz Rodriguez,Eugenia V. Gurevich,Maryka Quik,Michele Morari,Manuela Mellone,Fabrizio Gardoni,Elisabetta Tronci,Dominique Guehl,François Tison,Alan R. Crossman,Un Jung Kang,Kathy Steece-Collier,Susan H. Fox,Manolo Carta,M. Angela Cenci,Erwan Bezard +35 more
TL;DR: The present review attempts to provide an overview of the current understanding of dyskinesia and other L-dopa-induced dysfunctions to help in the development of novel therapeutic strategies aimed at preventing the generation of dyskinetic symptoms.
Journal ArticleDOI
Nicotine as a potential neuroprotective agent for Parkinson's disease.
TL;DR: Findings suggest that nicotine and nAChR drugs represent promising therapeutic agents for the management of Parkinson's disease.
Journal ArticleDOI
Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
Donato A. Di Monte,Alison L. McCormack,Giselle M. Petzinger,Ann Marie Janson,Maryka Quik,William J. Langston +5 more
TL;DR: Moderate nigrostriatal damage which does not induce clinical parkinsonism predisposes to levodopa‐induced dyskinesias, and the severity of denervation may enhance the sensitivity to subsequent levodOPA exposures.